Crossing the quality chasm for Clostridium difficile infection prevention

BMJ Quality and Safety

Volumn 24, Issue 7, 2015, Pages 409-411

  Safdar, Nasia ^a,c   Perencevich, Eli ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOODSTREAM INFECTION; CATHETER INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; EDITORIAL; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ORGANIZATION AND MANAGEMENT; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; STANDARDS;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; INFECTION CONTROL; RISK FACTORS;

EID: 84937427728     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2015-004344     Document Type: Editorial

References (17)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
2. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: a review. Arch Intern Med 2001;161:525-33.
3. Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect 2012;18(Suppl 6):5-12.
4. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758-64.
5. Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect 2013;66:115-28.
6. Power M, Wigglesworth N, Donaldson E, et al. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ 2010;341:c3359.
7. Cooke FJ, Holmes AH. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 2007;30:25-9.
8. Abbett SK, Yokoe DS, Lipsitz SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:1062-9.
9. Duerden BI. Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 2011;17:175-9.
10. Bishop J, Parry MF, Hall T. Decreasing Clostridium difficile infections in surgery: impact of a practice bundle incorporating a resident rounding protocol. Conn Med 2013;77:69-75.
11. Feazel LM, Malhotra A, Perencevich EN, et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 2014;69:1748-54.
12. Furuya EY, Dick A, Perencevich EN, et al. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS ONE 2011;6:e15452.
13. Chitnis AS, Magill SS, Edwards JR, et al. Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics 2012;130:e46-52.
14. Saint S, Greene MT, Kowalski CP, et al. Preventing catheterassociated urinary tract infection in the United States: a national comparative study. JAMA Intern Med 2013;173: 874-9.
15. Daneman N, Guttmann A, Wang X, et al. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf 2015;24:435-43.
16. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427-33.
17. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-55.